I guess I’ll just say it. No I believe Merck is
Post# of 157673
Not sure why they haven’t just said it yet.
https://www.biopharmadive.com/news/merck-deal...is/706309/
“The company is also developing combination formulations that pair Keytruda with other immunotherapies aimed at different cellular targets.“
As I had to point out once already today. Leronlimab is an immunotherapy!
Merck I’ll take 115 billon yesterday let’s get this show on the road.
Oh wait you said 15 billon. I guess we shall see.


CytoDyn Inc (CYDY) Stock Research Links
Case References
• HHS & SEC Whistleblower: HL-1412396
• DOJ Investigation Report / Whistleblower ID: 20250705-0001
• NIH Case Reference: CS1137565
• DoD Case: 16282
• IC IG / 50 U.S.C. §3033 / ARPA-H (Advanced Research Projects Agency for Health)
Founder & CEO
FireGate BioTech | AI Lux Veritas™
Contact FireGate Biotech
https://img1.wsimg.com/blobby/go/05a949a0-169...5_FULL.pdf